Biotech

All Articles

Rivus' phase 2 obesity-related heart failure trial reaches endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...

Ovid halts preclinical work, IV plan after soticlestat neglect

.Ovid Rehab presently showed last month that it was trimming back its headcount as the provider gets...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has opened up a $700 million R&ampD center in the Boston ma Port, boosting its own RNA as...

Boundless Biography makes 'reasonable' discharges 5 months after $100M IPO

.Simply 5 months after protecting a $one hundred million IPO, Vast Biography is actually presently g...

Halda's $126M is going to accelerate 'hold and also eliminate' tumor medications

.The initial stages of oncology R&ampD aren't short of fascinating brand-new techniques, and also Ha...

Lykos 'remorses' certainly not revealing research study violations with author

.Psychopharmacology has actually pulled 3 posts regarding midstage clinical test data evaluating Lyk...

Analysts examine Avidity's DMD gain, showing subtleties in information

.Avidity Biosciences satisfied capitalists along with period 1/2 information in Duchenne muscular dy...

Actinogen's cortisol blocker stops working stage 2 anxiety research

.Actinogen Medical's cortisol blocker has actually missed the key endpoint of a stage 2 study in anx...

Bivictrix determines going exclusive only means to take ADC in to clinic

.Antibody-drug conjugates (ADCs) have been at the center of several a billion-dollar biobuck licensi...

TPG bests up funds to $580M for expenditures around life scientific researches

.Resource supervisor TPG, which has assisted biotechs including Sionna Therapies as well as Santa An...